価格表

在庫・価格 : 2024年06月18日 11時55分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-ChREBP, Rabbit-Poly
データシート※最新のデータシートでない場合があります
NB400-135SS NOVノバス バイオロジカルス
Novus biologicals, LLC
0.025 ml ¥48,000
(未発注)
追加

在庫・価格 : 2024年06月18日 11時55分 現在

Anti-ChREBP, Rabbit-Poly

  • 商品コード:NB400-135SS
  • メーカー:NOV
  • 包装:0.025ml
  • 価格: ¥48,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Xu J et al. Regulation of rat hepatic L-pyruvate kinase promoter composition and activity by glucose, n-3 polyunsaturated fatty acids, and peroxisome proliferator-activated receptor-alpha agonist. J. Biol. Chem. 2006 Jul;281(27):18351-62
Xu J et al
2006/01/01
PubMed
2 Wang Y et al. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity. J. Lipid Res. 2006 Sep;47(9):2028-41
Wang Y et al
2006/01/01
PubMed
3 Dentin R et al. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes 2006 Aug;55(8):2159-70
Dentin R et al
2006/01/01
PubMed
4 Marmugi A et al. Low doses of bisphenol A induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver. Hepatology 2012 Feb;55(2):395-407
Marmugi A et al
2012/01/01
Applications: PubMed
5 Liu C et al. Oleanolic Acid diminishes liquid fructose-induced Fatty liver in rats: role of modulation of hepatic sterol regulatory element-binding protein-1c-mediated expression of genes responsible for de novo Fatty Acid synthesis. Evid Based Complement
Liu C et al
2013/01/01
Species: Rat, Applications: WB PubMed
6 Larter CZ et al. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis. J. Gastroenterol. Hepatol. 2012 Feb;27(2):341-50
Larter CZ et al
2012/01/01
Species: Mouse, Applications: WB PubMed
7 Perttil辰 J et al. PNPLA3 is regulated by glucose in human hepatocytes, and its I148M mutant slows down triglyceride hydrolysis. Am. J. Physiol. Endocrinol. Metab. 2012 May;302(9):E1063-9
Perttil辰 J et al
2012/01/01
Species: Human, Applications: ChIP PubMed
8 Fukasawa M et al. Coordinate regulation/localization of the carbohydrate responsive binding protein (ChREBP) by two nuclear export signal sites: discovery of a new leucine-rich nuclear export signal site. Biochem. Biophys. Res. Commun. 2010 Jan;391(2):116
Fukasawa M et al
2010/01/01
Species: Rat, Applications: EMSA PubMed
9 Xing X et al. Mangiferin treatment inhibits hepatic expression of acyl-coenzyme A:diacylglycerol acyltransferase-2 in fructose-fed spontaneously hypertensive rats: a link to amelioration of fatty liver. Toxicol. Appl. Pharmacol. 2014 Oct;280(2):207-15
Xing X et al
2014/01/01
Species: Rat, Applications: WB PubMed
10 Liu L et al. Modulation of hepatic sterol regulatory element-binding protein-1c-mediated gene expression contributes to Salacia oblonga root-elicited improvement of fructose-induced fatty liver in rats. J Ethnopharmacol 2013 Dec;150(3):1045-52
Liu L et al
2013/01/01
Species: Rat, Applications: WB PubMed
11 Dentin R et al. Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver. J. Hepatol. 2012 Jan;56(1):199-209
Dentin R et al
2012/01/01
Species: Mouse, Applications: WB PubMed
12 Vidal-Alabr坦 A et al. Liver Glucokinase(A456V) Induces Potent Hypoglycemia without Dyslipidemia through a Paradoxical Induction of the Catalytic Subunit of Glucose-6-Phosphatase. Int J Endocrinol 2011;2011:707928
Vidal-Alabr坦 A et al
2011/01/01
Applications: PubMed
13 Iizuka K et al. Rat glucagon receptor mRNA is directly regulated by glucose through transactivation of the carbohydrate response element binding protein. Biochem. Biophys. Res. Commun. 2012 Jan;417(4):1107-12
Iizuka K et al
2012/01/01
Applications: PubMed
14 Sirek AS et al. Insulin stimulates the expression of carbohydrate response element binding protein (ChREBP) by attenuating the repressive effect of Pit-1, Oct-1/Oct-2, and Unc-86 homeodomain protein octamer transcription factor-1. Endocrinology 2009 Aug;1
Sirek AS et al
2009/01/01
Species: Human, Applications: WB PubMed
15 Feingold KR et al. Endotoxin, zymosan, and cytokines decrease the expression of the transcription factor, carbohydrate response element binding protein, and its target genes. Innate Immun 2011 Apr;17(2):174-82
Feingold KR et al
2011/01/01
Species: Mouse, Applications: WB PubMed
16 Hagiwara A et al. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metab. 2012 May;15(5):725-38
Hagiwara A et al
2012/01/01
Species: Mouse, Applications: WB PubMed
17 Arden C et al. Fructose 2,6-bisphosphate is essential for glucose-regulated gene transcription of glucose-6-phosphatase and other ChREBP target genes in hepatocytes. Biochem. J. 2012 Apr;443(1):111-23
Arden C et al
2012/01/01
Species: Rat, Applications: ChIP, ICC/IF PubMed
18 Caron S et al. Farnesoid x receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytes. Mol. Cell. Biol. 2013 Jun;33(11):2202-11
Caron S et al
2013/01/01
Species: Human, Applications: ChIP PubMed
19 Tong X et al. The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 2009 Dec;106(51):21660-5
Tong X et al
2009/01/01
Species: Human, Mouse, Applications: WB PubMed
20 Wang Y et al. Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition. J. Lipid Res. 2008 Jul;49(7):1538-52
Wang Y et al
2008/01/01
Applications: PubMed
21 Petrie JL et al. Glucose induces protein targeting to glycogen in hepatocytes by fructose 2,6-bisphosphate-mediated recruitment of MondoA to the promoter. Mol. Cell. Biol. 2013 Feb;33(4):725-38
Petrie JL et al
2013/01/01
Species: Rat, Applications: ChIP PubMed
22 Burke SJ et al. cAMP prevents glucose-mediated modifications of histone H3 and recruitment of the RNA polymerase II holoenzyme to the L-PK gene promoter. J. Mol. Biol. 2009 Sep;392(3):578-88
Burke SJ et al
2009/01/01
Species: Rat, Applications: ChIP PubMed
23 Bu SY et al. Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity. J. Biol. Chem. 2009 Oct;284(44):30474-83
Bu SY et al
2009/01/01
Applications: PubMed
24 Shao W et al. Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes. PLoS ONE 2012;7(1):e28784
Shao W et al
2012/01/01
Applications: PubMed
25 Kim HJ et al. Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am. J. Physiol. Renal Physiol. 2009 Jun;296(6):F1297-306
Kim HJ et al
2009/01/01
Applications: PubMed
26 Jo SH et al. Txnip contributes to impaired glucose tolerance by upregulating the expression of genes involved in hepatic gluconeogenesis in mice. Diabetologia 2013 Dec;56(12):2723-32
Jo SH et al
2013/01/01
Species: Mouse, Applications: ChIP PubMed
27 Burke SJ et al. cAMP opposes the glucose-mediated induction of the L-PK gene by preventing the recruitment of a complex containing ChREBP, HNF4alpha, and CBP. FASEB J. 2009 Sep;23(9):2855-65
Burke SJ et al
2009/01/01
Applications: PubMed
28 Chang ML et al. High glucose activates ChREBP-mediated HIF-1α and VEGF expression in human RPE cells under normoxia. Adv. Exp. Med. Biol. 2014;801:609-21
Chang ML et al
2014/01/01
Species: Human, Applications: ChIP, WB, ICC/IF PubMed
29 Benhamed F et al. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. J. Clin. Invest. 2012 Jun;122(6):2176-94
Benhamed F et al
2012/01/01
Species: Mouse, Applications: WB PubMed
30 Iizuka K et al. Krüppel-like factor-10 is directly regulated by carbohydrate response element-binding protein in rat primary hepatocytes. Biochem. Biophys. Res. Commun. 2011 Sep;412(4):638-43
Iizuka K et al
2011/01/01
Applications: PubMed
31 Chambers KT et al. PGC-1β and ChREBP partner to cooperatively regulate hepatic lipogenesis in a glucose concentration-dependent manner. Mol Metab 2013;2(3):194-204
Chambers KT et al
2013/01/01
Species: Mouse, Applications: WB, ChIP PubMed
32 Jeong YS et al. Integrated expression profiling and genome-wide analysis of ChREBP targets reveals the dual role for ChREBP in glucose-regulated gene expression. PLoS ONE 2011;6(7):e22544
Jeong YS et al
2011/01/01
Applications: PubMed
33 Aneja KK et al. The presence of distal and proximal promoters for rat mitochondrial glycerol-3-phosphate acyltransferase. Arch. Biochem. Biophys. 2008 Feb;470(1):35-43
Aneja KK et al
2008/01/01
Applications: PubMed
34 Erhuma A et al. Prenatal exposure to a low-protein diet programs disordered regulation of lipid metabolism in the aging rat. Am. J. Physiol. Endocrinol. Metab. 2007 Jun;292(6):E1702-14
Erhuma A et al
2007/01/01
Applications: PubMed
35 Ido-Kitamura Y et al. Hepatic FoxO1 Integrates Glucose Utilization and Lipid Synthesis through Regulation of Chrebp O-Glycosylation. PLoS ONE 2012;7(10):e47231
Ido-Kitamura Y et al
2012/01/01
Species: Mouse, Applications: IP, WB PubMed
36 Arden C et al. Elevated glucose represses liver glucokinase and induces its regulatory protein to safeguard hepatic phosphate homeostasis. Diabetes 2011 Dec;60(12):3110-20
Arden C et al
2011/01/01
Applications: PubMed
37 Zhang P et al. c-Myc is required for the CHREBP-dependent activation of glucose-responsive genes. Mol. Endocrinol. 2010 Jun;24(6):1274-86
Zhang P et al
2010/01/01
Species: Human, Rat, Applications: ChIP, IP PubMed
38 Uebanso T et al. Paradoxical regulation of human FGF21 by both fasting and feeding signals: is FGF21 a nutritional adaptation factor? PLoS ONE 2011;6(8):e22976
Uebanso T et al
2011/01/01
Applications: PubMed
39 Guinez C et al. O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver. Diabetes 2011 May;60(5):1399-413
Guinez C et al
2011/01/01
Species: Mouse, Applications: ChIP, WB PubMed
40 Liu Y et al. Nuclear transport modulation reduces hypercholesterolemia, atherosclerosis, and fatty liver. J Am Heart Assoc 2013 Apr;2(2):e000093
Liu Y et al
2013/01/01
Species: Mouse, Applications: WB PubMed
41 Inoue J et al. Identification of MIG12 as a mediator for stimulation of lipogenesis by LXR activation. Mol. Endocrinol. 2011 Jun;25(6):995-1005
Inoue J et al
2011/01/01
Species: Mouse, Applications: ChIP PubMed
42 Boergesen M et al. ChREBP mediates glucose repression of peroxisome proliferator-activated receptor alpha expression in pancreatic beta-cells. J. Biol. Chem. 2011 Apr;286(15):13214-25
Boergesen M et al
2011/01/01
PubMed
43 Zhang YK et al. Nrf2 deficiency improves glucose tolerance in mice fed a high-fat diet. Toxicol. Appl. Pharmacol. 2012 Nov;264(3):305-14
Zhang YK et al
2012/01/01
Species: Mouse, Applications: WB PubMed
44 Kaadige MR et al. MondoA-Mlx Transcriptional Activity Is Limited by mTOR-MondoA Interaction. Mol. Cell. Biol. 2015 Jan;35(1):101-10
Kaadige MR et al
2015/01/01
Species: Human, Applications: WB PubMed
45 Oosterveer MH et al. LRH-1-dependent glucose sensing determines intermediary metabolism in liver. J. Clin. Invest. 2012 Aug;122(8):2817-26
Oosterveer MH et al
2012/01/01
Species: Mouse, Applications: WB PubMed
46 Wu L et al. Flightless I homolog negatively regulates ChREBP activity in cancer cells. Int. J. Biochem. Cell Biol. 2013 Nov;45(11):2688-97
Wu L et al
2013/01/01
Species: Human, Applications: IP, WB PubMed
47 Moon YA et al. Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice. J. Lipid Res. 2009 Mar;50(3):412-23
Moon YA et al
2009/01/01
PubMed
48 Jin K et al. Dysregulation of hepatic fatty acid metabolism in chronic kidney disease. Nephrol. Dial. Transplant. 2012 Oct;
Jin K et al
2012/01/01
Species: Rat, Applications: WB PubMed
49 Han S et al. Hepatic fatty acid and cholesterol metabolism in nephrotic syndrome. Am J Transl Res 2013;5(2):246-53
Han S et al
2013/01/01
Species: Rat, Applications: WB PubMed
  • No.: 1
  • 文献情報:
    Xu J et al. Regulation of rat hepatic L-pyruvate kinase promoter composition and activity by glucose, n-3 polyunsaturated fatty acids, and peroxisome proliferator-activated receptor-alpha agonist. J. Biol. Chem. 2006 Jul;281(27):18351-62
    Xu J et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Wang Y et al. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity. J. Lipid Res. 2006 Sep;47(9):2028-41
    Wang Y et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Dentin R et al. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes 2006 Aug;55(8):2159-70
    Dentin R et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Marmugi A et al. Low doses of bisphenol A induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver. Hepatology 2012 Feb;55(2):395-407
    Marmugi A et al
    2012/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Liu C et al. Oleanolic Acid diminishes liquid fructose-induced Fatty liver in rats: role of modulation of hepatic sterol regulatory element-binding protein-1c-mediated expression of genes responsible for de novo Fatty Acid synthesis. Evid Based Complement
    Liu C et al
    2013/01/01
  • 備考:
    Species: Rat, Applications: WB
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Larter CZ et al. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis. J. Gastroenterol. Hepatol. 2012 Feb;27(2):341-50
    Larter CZ et al
    2012/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Perttil辰 J et al. PNPLA3 is regulated by glucose in human hepatocytes, and its I148M mutant slows down triglyceride hydrolysis. Am. J. Physiol. Endocrinol. Metab. 2012 May;302(9):E1063-9
    Perttil辰 J et al
    2012/01/01
  • 備考:
    Species: Human, Applications: ChIP
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Fukasawa M et al. Coordinate regulation/localization of the carbohydrate responsive binding protein (ChREBP) by two nuclear export signal sites: discovery of a new leucine-rich nuclear export signal site. Biochem. Biophys. Res. Commun. 2010 Jan;391(2):116
    Fukasawa M et al
    2010/01/01
  • 備考:
    Species: Rat, Applications: EMSA
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Xing X et al. Mangiferin treatment inhibits hepatic expression of acyl-coenzyme A:diacylglycerol acyltransferase-2 in fructose-fed spontaneously hypertensive rats: a link to amelioration of fatty liver. Toxicol. Appl. Pharmacol. 2014 Oct;280(2):207-15
    Xing X et al
    2014/01/01
  • 備考:
    Species: Rat, Applications: WB
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Liu L et al. Modulation of hepatic sterol regulatory element-binding protein-1c-mediated gene expression contributes to Salacia oblonga root-elicited improvement of fructose-induced fatty liver in rats. J Ethnopharmacol 2013 Dec;150(3):1045-52
    Liu L et al
    2013/01/01
  • 備考:
    Species: Rat, Applications: WB
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Dentin R et al. Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver. J. Hepatol. 2012 Jan;56(1):199-209
    Dentin R et al
    2012/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Vidal-Alabr坦 A et al. Liver Glucokinase(A456V) Induces Potent Hypoglycemia without Dyslipidemia through a Paradoxical Induction of the Catalytic Subunit of Glucose-6-Phosphatase. Int J Endocrinol 2011;2011:707928
    Vidal-Alabr坦 A et al
    2011/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Iizuka K et al. Rat glucagon receptor mRNA is directly regulated by glucose through transactivation of the carbohydrate response element binding protein. Biochem. Biophys. Res. Commun. 2012 Jan;417(4):1107-12
    Iizuka K et al
    2012/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Sirek AS et al. Insulin stimulates the expression of carbohydrate response element binding protein (ChREBP) by attenuating the repressive effect of Pit-1, Oct-1/Oct-2, and Unc-86 homeodomain protein octamer transcription factor-1. Endocrinology 2009 Aug;1
    Sirek AS et al
    2009/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Feingold KR et al. Endotoxin, zymosan, and cytokines decrease the expression of the transcription factor, carbohydrate response element binding protein, and its target genes. Innate Immun 2011 Apr;17(2):174-82
    Feingold KR et al
    2011/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Hagiwara A et al. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metab. 2012 May;15(5):725-38
    Hagiwara A et al
    2012/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Arden C et al. Fructose 2,6-bisphosphate is essential for glucose-regulated gene transcription of glucose-6-phosphatase and other ChREBP target genes in hepatocytes. Biochem. J. 2012 Apr;443(1):111-23
    Arden C et al
    2012/01/01
  • 備考:
    Species: Rat, Applications: ChIP, ICC/IF
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Caron S et al. Farnesoid x receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytes. Mol. Cell. Biol. 2013 Jun;33(11):2202-11
    Caron S et al
    2013/01/01
  • 備考:
    Species: Human, Applications: ChIP
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Tong X et al. The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 2009 Dec;106(51):21660-5
    Tong X et al
    2009/01/01
  • 備考:
    Species: Human, Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Wang Y et al. Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition. J. Lipid Res. 2008 Jul;49(7):1538-52
    Wang Y et al
    2008/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Petrie JL et al. Glucose induces protein targeting to glycogen in hepatocytes by fructose 2,6-bisphosphate-mediated recruitment of MondoA to the promoter. Mol. Cell. Biol. 2013 Feb;33(4):725-38
    Petrie JL et al
    2013/01/01
  • 備考:
    Species: Rat, Applications: ChIP
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Burke SJ et al. cAMP prevents glucose-mediated modifications of histone H3 and recruitment of the RNA polymerase II holoenzyme to the L-PK gene promoter. J. Mol. Biol. 2009 Sep;392(3):578-88
    Burke SJ et al
    2009/01/01
  • 備考:
    Species: Rat, Applications: ChIP
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Bu SY et al. Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity. J. Biol. Chem. 2009 Oct;284(44):30474-83
    Bu SY et al
    2009/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Shao W et al. Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes. PLoS ONE 2012;7(1):e28784
    Shao W et al
    2012/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Kim HJ et al. Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am. J. Physiol. Renal Physiol. 2009 Jun;296(6):F1297-306
    Kim HJ et al
    2009/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Jo SH et al. Txnip contributes to impaired glucose tolerance by upregulating the expression of genes involved in hepatic gluconeogenesis in mice. Diabetologia 2013 Dec;56(12):2723-32
    Jo SH et al
    2013/01/01
  • 備考:
    Species: Mouse, Applications: ChIP
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Burke SJ et al. cAMP opposes the glucose-mediated induction of the L-PK gene by preventing the recruitment of a complex containing ChREBP, HNF4alpha, and CBP. FASEB J. 2009 Sep;23(9):2855-65
    Burke SJ et al
    2009/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Chang ML et al. High glucose activates ChREBP-mediated HIF-1α and VEGF expression in human RPE cells under normoxia. Adv. Exp. Med. Biol. 2014;801:609-21
    Chang ML et al
    2014/01/01
  • 備考:
    Species: Human, Applications: ChIP, WB, ICC/IF
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Benhamed F et al. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. J. Clin. Invest. 2012 Jun;122(6):2176-94
    Benhamed F et al
    2012/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Iizuka K et al. Krüppel-like factor-10 is directly regulated by carbohydrate response element-binding protein in rat primary hepatocytes. Biochem. Biophys. Res. Commun. 2011 Sep;412(4):638-43
    Iizuka K et al
    2011/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Chambers KT et al. PGC-1β and ChREBP partner to cooperatively regulate hepatic lipogenesis in a glucose concentration-dependent manner. Mol Metab 2013;2(3):194-204
    Chambers KT et al
    2013/01/01
  • 備考:
    Species: Mouse, Applications: WB, ChIP
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Jeong YS et al. Integrated expression profiling and genome-wide analysis of ChREBP targets reveals the dual role for ChREBP in glucose-regulated gene expression. PLoS ONE 2011;6(7):e22544
    Jeong YS et al
    2011/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Aneja KK et al. The presence of distal and proximal promoters for rat mitochondrial glycerol-3-phosphate acyltransferase. Arch. Biochem. Biophys. 2008 Feb;470(1):35-43
    Aneja KK et al
    2008/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Erhuma A et al. Prenatal exposure to a low-protein diet programs disordered regulation of lipid metabolism in the aging rat. Am. J. Physiol. Endocrinol. Metab. 2007 Jun;292(6):E1702-14
    Erhuma A et al
    2007/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Ido-Kitamura Y et al. Hepatic FoxO1 Integrates Glucose Utilization and Lipid Synthesis through Regulation of Chrebp O-Glycosylation. PLoS ONE 2012;7(10):e47231
    Ido-Kitamura Y et al
    2012/01/01
  • 備考:
    Species: Mouse, Applications: IP, WB
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Arden C et al. Elevated glucose represses liver glucokinase and induces its regulatory protein to safeguard hepatic phosphate homeostasis. Diabetes 2011 Dec;60(12):3110-20
    Arden C et al
    2011/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Zhang P et al. c-Myc is required for the CHREBP-dependent activation of glucose-responsive genes. Mol. Endocrinol. 2010 Jun;24(6):1274-86
    Zhang P et al
    2010/01/01
  • 備考:
    Species: Human, Rat, Applications: ChIP, IP
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Uebanso T et al. Paradoxical regulation of human FGF21 by both fasting and feeding signals: is FGF21 a nutritional adaptation factor? PLoS ONE 2011;6(8):e22976
    Uebanso T et al
    2011/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Guinez C et al. O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver. Diabetes 2011 May;60(5):1399-413
    Guinez C et al
    2011/01/01
  • 備考:
    Species: Mouse, Applications: ChIP, WB
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Liu Y et al. Nuclear transport modulation reduces hypercholesterolemia, atherosclerosis, and fatty liver. J Am Heart Assoc 2013 Apr;2(2):e000093
    Liu Y et al
    2013/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Inoue J et al. Identification of MIG12 as a mediator for stimulation of lipogenesis by LXR activation. Mol. Endocrinol. 2011 Jun;25(6):995-1005
    Inoue J et al
    2011/01/01
  • 備考:
    Species: Mouse, Applications: ChIP
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Boergesen M et al. ChREBP mediates glucose repression of peroxisome proliferator-activated receptor alpha expression in pancreatic beta-cells. J. Biol. Chem. 2011 Apr;286(15):13214-25
    Boergesen M et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Zhang YK et al. Nrf2 deficiency improves glucose tolerance in mice fed a high-fat diet. Toxicol. Appl. Pharmacol. 2012 Nov;264(3):305-14
    Zhang YK et al
    2012/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Kaadige MR et al. MondoA-Mlx Transcriptional Activity Is Limited by mTOR-MondoA Interaction. Mol. Cell. Biol. 2015 Jan;35(1):101-10
    Kaadige MR et al
    2015/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Oosterveer MH et al. LRH-1-dependent glucose sensing determines intermediary metabolism in liver. J. Clin. Invest. 2012 Aug;122(8):2817-26
    Oosterveer MH et al
    2012/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Wu L et al. Flightless I homolog negatively regulates ChREBP activity in cancer cells. Int. J. Biochem. Cell Biol. 2013 Nov;45(11):2688-97
    Wu L et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IP, WB
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Moon YA et al. Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice. J. Lipid Res. 2009 Mar;50(3):412-23
    Moon YA et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Jin K et al. Dysregulation of hepatic fatty acid metabolism in chronic kidney disease. Nephrol. Dial. Transplant. 2012 Oct;
    Jin K et al
    2012/01/01
  • 備考:
    Species: Rat, Applications: WB
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Han S et al. Hepatic fatty acid and cholesterol metabolism in nephrotic syndrome. Am J Transl Res 2013;5(2):246-53
    Han S et al
    2013/01/01
  • 備考:
    Species: Rat, Applications: WB
  • 参照:
    PubMed